Hyoscine Butylbromide Tablet Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 10 mg
Reference Brands: Buscopan(EU)
Category:
Gastrointestinal Drugs
Hyoscine Butylbromide tablets are antispasmodics that block parasympathetic nerve signals, relaxing smooth muscles in the gastrointestinal tract. They effectively reduce stomach and bowel spasms, relieving cramps, pain, and discomfort associated with gastrointestinal motility disorders. Benefits include symptom relief and improved digestive comfort.
Hyoscine Butylbromide tablet is available in Tablets
and strengths such as 10 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Hyoscine Butylbromide tablet is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Hyoscine Butylbromide tablet can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Hyoscine Butylbromide tablets, marketed as Buscopan, are approved in the EU for relief of bowel and stomach spasms. In the US, it is available as a generic for short-term spasm relief. Regulatory approval requires dossiers including clinical efficacy, safety data, manufacturing standards, and pharmacovigilance plans. The EU’s EMA evaluates safety and quality, while the FDA reviews clinical trial and manufacturing information for US approval. For dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Ensuring compliance supports timely approval, safe use, and global availability, helping patients manage gastrointestinal spasms effectively across regions worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing